Podophyllin office therapy against condyloma should be abandoned

Authors
von Krogh, G Longstaff, E
Citation
G. Von Krogh et E. Longstaff, Podophyllin office therapy against condyloma should be abandoned, SEX TRANS I, 77(6), 2001, pp. 409-412
Citations number
35
Categorie Soggetti
Clinical Immunolgy & Infectious Disease","da verificare
Journal title
SEXUALLY TRANSMITTED INFECTIONS
ISSN journal
13684973 → ACNP
Volume
77
Issue
6
Year of publication
2001
Pages
409 - 412
Database
ISI
SICI code
1368-4973(200112)77:6<409:POTACS>2.0.ZU;2-2
Abstract
Podophyllin, a crude plant extract with low efficacy, high toxicity, and a serious mutagenicity profile does not comply with the WHO guidelines for pl ant derived treatments and should be removed from clinical treatment protoc ols. Home treatment with pharmaceutical products based on podophyllotoxin-t he purified, standardised active antiwart ingredient of podophyllin-represe nts safe and effective first line therapy for patients with anogenital wart s.